Correlation Between Aquestive Therapeutics and Scandinavian Tobacco

Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Scandinavian Tobacco at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Scandinavian Tobacco into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aquestive Therapeutics and Scandinavian Tobacco Group, you can compare the effects of market volatilities on Aquestive Therapeutics and Scandinavian Tobacco and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Scandinavian Tobacco. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Scandinavian Tobacco.

Diversification Opportunities for Aquestive Therapeutics and Scandinavian Tobacco

0.72

Correlation Coefficient

Aquestive Therapeutics  Scandinavian Tobacco

Poor diversification

The 3 months correlation between Aquestive and Scandinavian is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Scandinavian Tobacco Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scandinavian Tobacco and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Scandinavian Tobacco. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scandinavian Tobacco has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Scandinavian Tobacco go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Scandinavian Tobacco

Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 2.74 times more return on investment than Scandinavian Tobacco. However, Aquestive Therapeutics is 2.74 times more volatile than Scandinavian Tobacco Group. It trades about 0.05 of its potential returns per unit of risk. Scandinavian Tobacco Group is currently generating about 0.01 per unit of risk. If you would invest  208.00  in Aquestive Therapeutics on October 3, 2024 and sell it today you would earn a total of  148.00  from holding Aquestive Therapeutics or generate 71.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.49%
Values	Daily Returns

Aquestive Therapeutics  vs.  Scandinavian Tobacco Group

Aquestive Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Scandinavian Tobacco

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scandinavian Tobacco Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Aquestive Therapeutics and Scandinavian Tobacco

The main advantage of trading using opposite Aquestive Therapeutics and Scandinavian Tobacco positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Scandinavian Tobacco can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scandinavian Tobacco will offset losses from the drop in Scandinavian Tobacco's long position.

The idea behind Aquestive Therapeutics and Scandinavian Tobacco Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.